Lunger John

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
26
Insider Sells Sum
$217,956.68

Insider Activity of Lunger John

According to the SEC Form 4 filings, Lunger John, being in a position of

  1. Chief Patient Supply Officer at Adaptimmune Therapeutics plc,
    оver the last 12 months, has bought 0 shares, and sold 25126 shares for $14,604,
    over all time since 2020-01-06, has bought 0 shares, and sold 108284 shares for $217,957.

The largest sale of all time was on 2020-08-03 and amounted to 4823 shares of Adaptimmune Therapeutics plc for $44,613.

Biography of Lunger John

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $14,6043100

Comparison of Insiders on Amount of Buys and Sells

2025-01-17SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
5,584
0.0022%
$0.58$3,243-1.26%
2025-01-15SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
9,803
0.0036%
$0.57$5,635-5.57%
2025-01-13SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
9,739
0.0038%
$0.59$5,726-3.66%
2024-01-17SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
18,114
0.0075%
$0.67$12,191+43.43%
2024-01-16SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
4,681
0.0023%
$0.79$3,698+46.48%
2024-01-12SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
5,220
0.0024%
$0.85$4,458+26.38%
2024-01-11SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
4,009
0.0017%
$0.84$3,354+18.2%
2023-08-01SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
3,096
0.0013%
$0.91$2,804-3.1%
2023-01-17SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
4,440
0.0029%
$1.86$8,250-47.14%
2023-01-12SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
4,973
0.0028%
$1.71$8,484-49.29%
2023-01-11SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
3,843
0.0023%
$1.75$6,713-48.04%
2023-01-04SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
1,100
0.0006%
$1.69$1,863-47.53%
2022-08-01SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
2,983
0.0019%
$1.77$5,290-20.69%
2022-07-05SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
1,973
0.0012%
$1.68$3,311-12.05%
2022-01-18SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
4,368
0.0029%
$3.19$13,942-40.52%
2022-01-12SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
1,076
0.0007%
$3.54$3,813-46.49%
2022-01-11SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
3,770
0.0024%
$3.56$13,409-48.88%
2022-01-04SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
1,070
0.0007%
$4.06$4,349-52.08%
2021-08-02SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
2,939
0.0019%
$3.58$10,536-16.06%
2021-07-02SaleAdaptimmune Therapeutics plc
ADAP
Chief Patient Supply Officer
1,907
0.0012%
$4.26$8,133-18.56%
Total: 26
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.